title: Clinical scenarios in IBD: optimizing the use of conventional and biologic agents.
authors.forename: Stephen B
authors.initials: SB
authors.lastname: Hanauer
authors.forename: Asher A
authors.initials: AA
authors.lastname: Kornbluth
authors.forename: Julie
authors.initials: J
authors.lastname: Messick
authors.forename: David T
authors.initials: DT
authors.lastname: Rubin
authors.forename: William J
authors.initials: WJ
authors.lastname: Sandborn
authors.forename: Bruce E
authors.initials: BE
authors.lastname: Sands
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001688:Biological Products / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003226:Congresses as Topic; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*
chemical_list: D000893:Anti-Inflammatory Agents; D001688:Biological Products